Bridget E. Bunner

Array ( [id] => 7776309 [patent_doc_number] => 20120039890 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-02-16 [patent_title] => 'METHODS OF TREATMENT USING ANTIBODIES TO NEUTROKINE-ALPHA' [patent_app_type] => utility [patent_app_number] => 12/870548 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 162853 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0039/20120039890.pdf [firstpage_image] =>[orig_patent_app_number] => 12870548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343342 [patent_doc_number] => 20100330073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'METHODS OF TREATMENT USING ANTIBODIES TO NEUTROKINE-ALPHA' [patent_app_type] => utility [patent_app_number] => 12/870394 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 162891 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330073.pdf [firstpage_image] =>[orig_patent_app_number] => 12870394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024918 [patent_doc_number] => 20110053244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'NOVEL PROTEIN DELIVERY SYSTEM TO GENERATE INDUCED PLURIPOTENT STEM (iPS) CELLS OR TISSUE-SPECIFIC CELLS' [patent_app_type] => utility [patent_app_number] => 12/870782 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7013 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053244.pdf [firstpage_image] =>[orig_patent_app_number] => 12870782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209016 [patent_doc_number] => 20120128682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'APOLIPOPROTEIN L- I VARIANTS AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/388645 [patent_app_country] => US [patent_app_date] => 2010-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3686 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128682.pdf [firstpage_image] =>[orig_patent_app_number] => 13388645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8312669 [patent_doc_number] => 20120189690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'Liposomes covered with the Extracellular Domain of the APO2L/Trail Protein' [patent_app_type] => utility [patent_app_number] => 13/391582 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12733 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13391582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8689948 [patent_doc_number] => 08389475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Relaxin analogs' [patent_app_type] => utility [patent_app_number] => 12/852373 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13787 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12852373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007083 [patent_doc_number] => 20110059114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'Compositions and Methods for the Treatment of Radioresistant Glioma Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/851482 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13125 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059114.pdf [firstpage_image] =>[orig_patent_app_number] => 12851482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8220811 [patent_doc_number] => 20120135011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'Method for in vivo expansion of T regulatory cells' [patent_app_type] => utility [patent_app_number] => 13/388722 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20609 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209975 [patent_doc_number] => 20120129189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'Methods of Controlling Cell Proliferation' [patent_app_type] => utility [patent_app_number] => 13/383819 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 29052 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129189.pdf [firstpage_image] =>[orig_patent_app_number] => 13383819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8264731 [patent_doc_number] => 20120164159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'Humanised Antibodies to Toll-Like Receptor 2 and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/382044 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 29006 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10050824 [patent_doc_number] => 09090690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-28 [patent_title] => 'Anti Notch-1 antibodies' [patent_app_type] => utility [patent_app_number] => 13/378791 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 27042 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254411 [patent_doc_number] => 08617822 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Method of inhibiting binding or activity of MIF by administering a MIF antagonist' [patent_app_type] => utility [patent_app_number] => 12/781546 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 6989 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12781546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8197029 [patent_doc_number] => 20120121588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'MODULATION OF PILR RECEPTORS TO TREAT SEPSIS' [patent_app_type] => utility [patent_app_number] => 13/321406 [patent_app_country] => US [patent_app_date] => 2010-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18536 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121588.pdf [firstpage_image] =>[orig_patent_app_number] => 13321406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8822295 [patent_doc_number] => 20130123340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIAC ISCHEMIC INJURY' [patent_app_type] => utility [patent_app_number] => 13/697365 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 32105 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13697365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476013 [patent_doc_number] => 20100284986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF MIGRAINES' [patent_app_type] => utility [patent_app_number] => 12/774536 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2127 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0284/20100284986.pdf [firstpage_image] =>[orig_patent_app_number] => 12774536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134450 [patent_doc_number] => 20110008352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Toll-Like Receptor 3 Antagonists' [patent_app_type] => utility [patent_app_number] => 12/770147 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34773 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008352.pdf [firstpage_image] =>[orig_patent_app_number] => 12770147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6392480 [patent_doc_number] => 20100303867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => ' A COMPOSITION COMPRISING A NOTCH LIGAND AND AN ALLERGENB OR ALLERGEN BYSTANDER ANTIGEN' [patent_app_type] => utility [patent_app_number] => 12/766738 [patent_app_country] => US [patent_app_date] => 2010-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 47887 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303867.pdf [firstpage_image] =>[orig_patent_app_number] => 12766738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9608225 [patent_doc_number] => 08785392 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Method for inhibiting cancer metastasis by administration of the extracellular domain DLK1 or a DLK1-FC fusion protein' [patent_app_type] => utility [patent_app_number] => 13/142818 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 8185 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13142818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952451 [patent_doc_number] => 20110033481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'PROSPECTIVE IDENTIFICATION AND CHARACTERIZATION OF BREAST CANCER STEM CELLS' [patent_app_type] => utility [patent_app_number] => 12/758540 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 61102 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033481.pdf [firstpage_image] =>[orig_patent_app_number] => 12758540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125361 [patent_doc_number] => 20110086020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'Agent exhibiting immunoregulatory properties and the use thereof for treating autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 12/798027 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6041 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086020.pdf [firstpage_image] =>[orig_patent_app_number] => 12798027 [rel_patent_id] =>[rel_patent_doc_number] =>)